The VIOLET Trial: A Pragmatic Phase II Study to Optimize Neoadjuvant Treatment and Surgical De-escalation in HR+/HER2- Early Breast Cancer Using Oncotype DX and Abemaciclib

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source

ClinicalTrials.gov

Source record ID

NCT07428018

Title field or adapter rule

protocolSection.identificationModule.officialTitle

Ingested At

2026-04-25T22:28:18.355461+00:00

Published At

2026-03-05T00:00:00+00:00

Record Updated At

2026-03-05

Timestamp Basis

source retrieval time was not retained by the feed adapter

Date limitation

source retrieval time was not retained by the feed adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions

["Breast Cancer", "HER2 + Breast Cancer", "HR Positive", "Neoadjuvant Therapy"]

protocolSection.statusModule.lastUpdatePostDateStruct.date

"2026-03-05"

protocolSection.identificationModule.nctId

"NCT07428018"

protocolSection.identificationModule.officialTitle

"The VIOLET Trial: A Pragmatic Phase II Study to Optimize Neoadjuvant Treatment and Surgical De-escalation in HR+/HER2- Early Breast Cancer Using Oncotype DX and Abemaciclib"

protocolSection.statusModule.overallStatus

"NOT_YET_RECRUITING"

protocolSection.designModule.phases

["PHASE2"]

protocolSection.statusModule.resultsFirstPostDateStruct.date

""

Study condition terms

• Breast Cancer (protocolSection.conditionsModule.conditions)
• HER2 + Breast Cancer (protocolSection.conditionsModule.conditions)
• HR Positive (protocolSection.conditionsModule.conditions)
• Neoadjuvant Therapy (protocolSection.conditionsModule.conditions)

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.